Melanoma is one of the most aggressive malignant formations. It takes the lives of young people: many patients are in the age category of 30-40 years. Melanoma...
Immunotherapy for melanoma is the treatment of choice for patients with metastatic tumors, resistance to chemotherapeutic agents, and disease recurrence after the successful initial treatment. Vaccination with dendritic cells reboots a person's immunity, teaching it to find and attack melanoma cells throughout the body.
Prostate cancer immunotherapy is a modern treatment option for men with stage 4 cancer who have already undergone surgery and received chemotherapy and hormone treatment. Immunotherapy works where other treatments have failed and can no longer stop cancer progression. When restoring a man's antitumor immunity...
The American Society of Clinical Oncology publishes a Clinical Cancer Advances report annually. CAR T-cell therapy was presented as one of the main achievements of the year in the report for 2018. This therapy was a breakthrough in oncology, mainly in the treatment of hematologic diseases. Today, some countries use CAR T immunotherapy not only in clinical trials, but also in practical medicine.
Kidney cancer is one of the most common types of malignant tumors. More than 250,000 cases are diagnosed in the world every year. According to statistics, it usually develops in people aged between 60 and 65 years of age. The disease is most often detected at its early stages, but stage 4 cancer is diagnosed in every sixth patient.
Liver cancer usually develops between the ages of 50 and 65. It is less common than other malignant tumors. It ranks 5th in terms of incidence rates among men and 8th amongst women. In 75% of cases, the disease is detected at an advanced stage, it is then usually treated with radical surgery. Nowadays, Germany is actively developing...
Stem cell treatment of joints has been studied far more than in the treatment of other diseases. This therapy helps to thicken the cartilaginous tissue and eliminate pain. As a result, the mobility of the patient is restored. This process uses the ability of stem cells to regenerate - the cells are injected into any tissue.
Alzheimer's disease (AD) is a major public health problem. According to the Alzheimer's Association, about 6.2 million people are living with the disease in the USA alone, and that number is projected to rise to nearly 14 million by 2050. Classic treatment eliminates symptoms and does not affect the underlying cause of the...